Cambridge Investment Research Advisors’s Amdocs DOX Stock Holding History
Bought
Maintained
Sold
Other funds holding DOX
BGC
BIP
Cambridge Investment Research Advisors's DOX Position: Q2 2026 in Review
Cambridge Investment Research Advisors reduced its Amdocs (DOX) stake by 3.5% in Q2 2026, selling an estimated $15.3K and leaving 6,828 shares worth $345K. The position accounts for ﹤0.01% of the portfolio, ranked #3323.
Cambridge Investment Research Advisors first reported a position in DOX in Q2 2022 and has held it in 17 quarters since. The position peaked at $2.27M in Q2 2023. 447 funds tracked by Wall St. Rank hold DOX as of Q2 2026.
- Cambridge Investment Research Advisors held 6,828 shares of Amdocs worth $345K as of Q2 2026.
- Cambridge Investment Research Advisors sold 250 Amdocs shares in Q2 2026, an estimated $15.3K.
- Amdocs made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #3323 holding.
- Cambridge Investment Research Advisors first reported a position in Amdocs in Q2 2022 and has held it in 17 quarters since.
- Cambridge Investment Research Advisors's Amdocs position peaked at $2.27M in Q2 2023.
- 447 funds tracked by Wall St. Rank held Amdocs as of Q2 2026.
Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.